• FirefoxInstall the new Firefox »
  •  Dow Down0.45% Nasdaq Down0.49%

    ImmuCell Corp. (ICCC)

    -NasdaqCM
    6.65 Down 0.25(3.62%) Feb 27, 3:38PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 6,007   5,390   5,111  
    Cost of Revenue2,947  2,336  2,297  
    Gross Profit 3,061   3,054   2,814  
    Operating Expenses
    Research Development1,154  918  1,720  
    Selling General and Administrative1,926  1,892  1,726  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (20) 245   (633)
    Income from Continuing Operations
    Total Other Income/Expenses Net225  (53)(64)
    Earnings Before Interest And Taxes205  192  (697)
    Interest Expense -   -   -  
    Income Before Tax205  192  (697)
    Income Tax Expense88  103  (287)
    Minority Interest -   -   -  
    Net Income From Continuing Ops117  90  (410)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 117   90   (410)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 117   90   (410)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.